Skip to content

DataLookout

Sign in Start free

TBCSNCT06337578

Advances in Telephone-based Cognitive Screening Procedures

StatusUnknown

PhaseNot specified

SponsorIstituto Auxologico Italiano

Primary completionOct 25, 2026 (estimated)

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

Minor Changed Nov 1, 2026 Registry marked status Unknown (sponsor has not verified the record since Mar 2024); last known: Recruiting
Mar 22, 2024 Study First Submitted

Minor: routine updates

Endpoints

Primary

ALS Cognitive Behavioral Screen-Phone Version in ALS patients

Timeframe: At enrollment and at 6 months, 12 months and 18 months of follow-up

Telephone Interview for Cognitive Status in AD, LBD, FTD and CVD patients

Timeframe: At enrollment and at 6 months, 12 months and 18 months of follow-up

Telephone-based Frontal Assessment Battery in ALS, AD, LBD, FTD and CVD patients

Timeframe: At enrollment and at 6 months, 12 months and 18 months of follow-up

Telephone Language Screener in ALS, AD, LBD, FTD and CVD patients

Timeframe: At enrollment and at 6 months, 12 months and 18 months of follow-up

Telephone-based Verbal Fluency Battery in ALS, AD, LBD, FTD and CVD patients

Timeframe: At enrollment and at 6 months, 12 months and 18 months of follow-up

Mini-Mental State Examination in NI

Timeframe: At enrollment and at 6 months, 12 months and 18 months of follow-up

Montreal Cognitive Assessment in NI

Timeframe: At enrollment and at 6 months, 12 months and 18 months of follow-up

Arms and interventions

Patients with amyotrophic lateral sclerosis (ALS)

Individuals having been received a clinical diagnosis of amyotrophic lateral sclerosis according to current diagnostic criteria

Patients with Alzheimer's disease (AD)

Individuals having been received a neurochemical and/or aclinical diagnosis of Alzheimer's according to current diagnostic criteria

Patients with Lewy body dementia (LBD)

Individuals having been received a clinical diagnosis of Lewy body dementia according to current diagnostic criteria

Patients with frontotemporal dementia (FTD)

Individuals having been received a clinical diagnosis of frontotemporal dementia (i.e., behavioural variant-frontotemporal dementia; semantic dementia; progressive non-fluent aphasia) according to current diagnostic criteria

Patients with chronic cerebrovascular disorders (CVD)

Individuals with mild cognitive impairment/dementia and neuroradiological evidence of chronic cerebrovascular diseases

Normotypical individuals (NI)

Individuals without brain disorders

Behavioral: Telephone-based neuropsychological assessment - ALS, Telephone-based neuropsychological assessment - AD, LBD, FTD and CVD, Telephone-based and in-person cognitive screening - NIs

Sites

1 site in 1 country

Istituto Auxologico ItalianoMilan, Italy

About this trial

1. Background Cognitive screening procedures via performance-based tests represent an essential, albeit preliminary, element within the diagnostic and interventional process as addressed to patients with chronic neurological disorders. Furthermore, in these populations, cognitive screening measures are often employed as outcomes in epidemiological settings, as well as endpoints in clinical trials. Therefore, cognitive screeners need to possess robust clinimetric and clinical usability properties - the investigation of which must be country-specific (i.e., specific to each language and culture). The need for such clinimetric and feasibility studies is even more true if referred to telephone-based cognitive screening (TBCS) procedures - which, until recently, have been mostly neglected in Italy, despite having the potential to bring clear benefits to clinical practice and research. In fact, TBCS techniques allow, through the use of a very widespread, accessible and easy-to-use telecommunication medium, to break down the geographical, logistical, socio-demographic and organizational barriers that make it difficult and/or prevent 1) access to these clinical services and 2) the continuity of their provision, as well as the creation and completion of 3) large-scale epidemiological studies and 4) decentralized clinical trials. However, although some TBCS tests have recently been developed and standardized in Italy, their clinimetric properties and clinical usability in populations with chronic neurological disorders have not yet been investigated. Furthermore, currently, the "paper-and-pencil" version of the international gold-standard for TBCS procedures . i.e. the Telephone Interview For Cognitive Status (TICS), which has been recently standardized in this country - is not available within the Italian scenario. In fact, although the feasibility of a de visu version of the TICS (i.e., In-Person TICS; IP-TICS) has been demonstrated in this country, an actual standardization of this test has not yet been implemented to date. Such a tool would, however, allow flexible use of screening assessments, regardless of the delivery method, both in clinical and experimental contexts. 2. Aims The present study primarily aims to provide exhaustive evidence regarding the psychometric, diagnostic and both cross-sectional and longitudinal clinical usability of TBCS that are currently available within the Italian scenario in populations with chronic neurological disorders. Secondly, this study aims to derive, in normotypical Italian subjects, 1) normative data for the IP-TICS and 2) the conversion algorithms between the latter (and other widely used "paper-and-pencil" screeners ) and the TICS. 3. Methods The study is monocentric, observational, prospective. Over a period of 3 years, patients who have already undergone an in-person cognitive screening session within 6 months prior to recruitment and falling under the following diagnostic categories will be recruited: 1) amyotrophic lateral sclerosis (N≥88); 2) Alzheimer's disease (N≥66); 3) Lewy body dementia (N≥30); 4) frontotemporal dementia (N≥30); 5) chronic cerebrovascular disorders (N≥66). Furthermore, N≥287 normotypical subjects representative of the Italian population will be recruited. The following TBCS tests will be administered to patients: 1) TICS; 2) Telephone-based Frontal Assessment Battery; 3) Telephone Language Screener; 4) Telephone-based Verbal Fluency Battery; 5) ALS Cognitive Behavioral Screen-Phone Version. Additionally, patients will undergo a functional evaluation using caregiver-report questionnaires evaluating instrumental and non-instrumental skills of daily living and behavioral changes. Normal subjects will instead be administered: 1) TICS; 2) IP-TICS; 3) Mini-Mental State Examination (MMSE); 4) Montreal Cognitive Assessment (MoCA). In patients, telephone follow-ups are expected after 6, 12 and 18 months. Statistical analyses will be carried out aimed at 1) the detailed study, in patients, of the psychometrics, diagnostics and cross-sectional/longitudinal clinical usability of the aforementioned TBCS test, as well as at 2) the derivation, in normotypical subjects, of the normative data of the IP-TICS and MoCA Memory Index Score (MIS), as well as the conversion algorithms between TICS and IP-TICS/MMSE/MoCA.

Trial details

Enrollment: 280 participants (estimated)
Started: Oct 25, 2023
Study completion: Oct 25, 2026 (estimated)
Eligibility: 18 and older, all sexes, healthy volunteers accepted
Design: Observational
Conditions: Alzheimer Disease, Amyotrophic Lateral Sclerosis, Cerebrovascular Disorders, Lewy Body Disease, Alzheimer's Disease, Lewy Body Dementia, Frontotemporal Degeneration
Official title: Avanzamenti in Materia di Screening Cognitivo Telefonico
First posted: Mar 29, 2024
Registry updated: Mar 29, 2024
Last verified: Mar 2024
Record status: This record was last updated March 29, 2024 (before its estimated October 25, 2026 completion). Its status may not reflect the trial's current state.

Related trials at risk

View on ClinicalTrials.gov ↗